Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
Clinical trial NCT02290210 · COMPLETED
Trial details
- NCT number
- NCT02290210
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-24
- Primary completion
- 2014-12-02
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.